Transfer learning for drug-target interaction prediction

ArticleAçık Erişim

Özet

Motivation: Utilizing AI-driven approaches for drug-target interaction (DTI) prediction require large volumes of training data which are not available for the majority of target proteins. In this study, we investigate the use of deep transfer learning for the prediction of interactions between drug candidate compounds and understudied target proteins with scarce training data. The idea here is to first train a deep neural network classifier with a generalized source training dataset of large size and then to reuse this pre-trained neural network as an initial configuration for re-training/fine-tuning purposes with a small-sized specialized target training dataset. To explore this idea, we selected six protein families that have critical importance in biomedicine: kinases, G-protein-coupled receptors (GPCRs), ion channels, nuclear receptors, proteases, and transporters. In two independent experiments, the protein families of transporters and nuclear receptors were individually set as the target datasets, while the remaining five families were used as the source datasets. Several size-based target family training datasets were formed in a controlled manner to assess the benefit provided by the transfer learning approach. Results: Here, we present a systematic evaluation of our approach by pre-training a feed-forward neural network with source training datasets and applying different modes of transfer learning from the pre-trained source network to a target dataset. The performance of deep transfer learning is evaluated and compared with that of training the same deep neural network from scratch. We found that when the training dataset contains fewer than 100 compounds, transfer learning outperforms the conventional strategy of training the system from scratch, suggesting that transfer learning is advantageous for predicting binders to under-studied targets. © 2023 The Author(s). Published by Oxford University Press.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12307Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorDalklran, Alperen
dc.contributor.authorAtakan, Ahmet
dc.contributor.authorRifaioǧlu, Ahmet S
dc.contributor.authorMartin, Maria J
dc.contributor.authorAtalay, Rengül Çetin
dc.contributor.authorAcar, Aybar C
dc.contributor.authorDoǧan, Tunca
dc.contributor.authorAtalay, Volkan
dc.date.accessioned2026-10-18T20:27:13.174760672Z
dc.date.available2026-10-18T20:27:13.174760672Z
dc.date.issued2023
dc.description.abstractMotivation: Utilizing AI-driven approaches for drug-target interaction (DTI) prediction require large volumes of training data which are not available for the majority of target proteins. In this study, we investigate the use of deep transfer learning for the prediction of interactions between drug candidate compounds and understudied target proteins with scarce training data. The idea here is to first train a deep neural network classifier with a generalized source training dataset of large size and then to reuse this pre-trained neural network as an initial configuration for re-training/fine-tuning purposes with a small-sized specialized target training dataset. To explore this idea, we selected six protein families that have critical importance in biomedicine: kinases, G-protein-coupled receptors (GPCRs), ion channels, nuclear receptors, proteases, and transporters. In two independent experiments, the protein families of transporters and nuclear receptors were individually set as the target datasets, while the remaining five families were used as the source datasets. Several size-based target family training datasets were formed in a controlled manner to assess the benefit provided by the transfer learning approach. Results: Here, we present a systematic evaluation of our approach by pre-training a feed-forward neural network with source training datasets and applying different modes of transfer learning from the pre-trained source network to a target dataset. The performance of deep transfer learning is evaluated and compared with that of training the same deep neural network from scratch. We found that when the training dataset contains fewer than 100 compounds, transfer learning outperforms the conventional strategy of training the system from scratch, suggesting that transfer learning is advantageous for predicting binders to under-studied targets. © 2023 The Author(s). Published by Oxford University Press.
dc.description.sponsorshipThis work was supported by TUBITAK project number: 121E208.
dc.identifier.doi10.1093/bioinformatics/btad234
dc.identifier.endpageI110
dc.identifier.issn1367-4803
dc.identifier.issue39 Suppl 1
dc.identifier.pmcidPMC10311347
dc.identifier.pmid37387156
dc.identifier.scopus2-s2.0-85163622323
dc.identifier.startpageI103
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12307
dc.identifier.volume39
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartofBioinformatics
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMachine Learning
dc.subjectNeural Networks, Computer
dc.subjectPeptide Hydrolases
dc.subjectSoftware
dc.subjectpeptide hydrolase
dc.subjectartificial neural network
dc.titleTransfer learning for drug-target interaction prediction
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus56
rdl.departmentDepartment of Computer Engineering, Erzincan Binali Yıldırım University, Erzincan 24002, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexPUBMED